Assessing risk and managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNFα treatment

被引：4
作者：
Ormerod, LP [1 ]
机构：
[1] Blackburn Royal Infirm, Chest Clin, Blackburn BB2 3LR, Lancs, England
[2] Univ Cent Lancashire, Lancashire Postgrad Sch Med & Hlth, Preston PR1 2HE, Lancs, England
来源：
CYTOKINE | 2004年 / 28卷 / 4-5期
关键词：
tuberculosis; latent infection; anti-TNF-alpha treatment;
D O I：
10.1016/j.cyto.2004.07.013
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
This short paper describes the, rationale being applied in the United Kingdom to the problem of treating latent TB infection in persons requiring anti-TNF-alpha treatment. This will largely have to be done by an individual risk/benefit analysis based on the risks of developing disease from national epidemiology compared with the risks of significant hepatotoxicity from treatment of latent infection. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：179 / 181
页数：3
相关论文
共 10 条
  • [1] DISTURBED HEPATIC FUNCTION DURING ISONIAZID CHEMOPROPHYLAXIS - MONITORING HEPATIC FUNCTION OF 427 HOSPITAL EMPLOYEES RECEIVING ISONIAZID CHEMOPROPHYLAXIS FOR TUBERCULOSIS
    BAILEY, WC
    TAYLOR, SL
    DASCOMB, HE
    GREENBERG, HB
    ZISKIND, MM
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1973, 107 (04): : 523 - 529
  • [2] GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36
  • [3] Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: A multicenter clinical trial
    Jasmer, RM
    Saukkonen, JJ
    Blumberg, HM
    Daley, CL
    Bernardo, J
    Vittinghoff, E
    King, MD
    Kawamura, LM
    Hopewell, PC
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 137 (08) : 640 - 647
  • [4] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
    Keane, J
    Gershon, S
    Wise, RP
    Mirabile-Levens, E
    Kasznica, J
    Schwieterman, WD
    Siegel, JN
    Braun, MM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) : 1098 - 1104
  • [5] Tuberculosis in England and Wales in 1993: results of a national survey
    Kumar, D
    Watson, JM
    Charlett, A
    Nicholas, S
    Darbyshire, JH
    [J]. THORAX, 1997, 52 (12) : 1060 - 1067
  • [6] Hepatotoxicity associated with isoniazid preventive therapy - A 7-year survey from a public health tuberculosis clinic
    Nolan, CM
    Goldberg, SV
    Buskin, SE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (11): : 1014 - 1018
  • [7] Ormerod P, 1998, THORAX, V53, P536
  • [8] Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998
    Rose, AMC
    Watson, JM
    Graham, C
    Nunn, AJ
    Drobniewski, F
    Ormerod, LP
    Darbyshire, JH
    Leese, J
    [J]. THORAX, 2001, 56 (03) : 173 - 179
  • [9] THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555
  • [10] Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
    Wolfe, F
    Michaud, K
    Anderson, J
    Urbansky, K
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (02): : 372 - 379
1